Материалов:
1 082 141

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 31651

Страница 4 из 3166

Immunohistochemical Study of Tumor Cells Proliferative Activity at Different Graduations of Prostate Cancer
Kudryavtsev G.Y., Kudryavtseva L.V., Mikhaleva L.M., Babichenko I.I.
as to compare this indicator with the clinical stage of the disease, the level of prostate-specific antigen
ФЛУОРЕСЦЕНТНЫЕ КОНЪЮГАТЫ НА ОСНОВЕ ЛИГАНДОВ ПРОСТАТИЧЕСКОГО СПЕЦИФИЧЕСКОГО МЕМБРАННОГО АНТИГЕНА КАК ЭФФЕКТИВНОЕ СРЕДСТВО ВИЗУАЛИЗАЦИИ ОПУХОЛЕЙ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
Успенская А.А., Красников П.А., Мажуга А.Г., Белоглазкина Е.К., Мачулкин А.Э.
correct diagnosis. In the case of PC, the protein marker is prostate specific membrane antigen (PSMA
Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies
Hamm C.A., Baumgärtner G.L., Padhani A.R., Froböse K.P., Dräger Franziska, Beetz N.L., Savic L.J., Posch Helena, Lenk Julian, Schallenberg Simon, Maxeiner Andreas, Cash Hannes, Günzel Karsten, Hamm Bernd, Asbach Patrick, Penzkofer Tobias
and test zone-specific prostate-specific antigen density (sPSAD) combined with PI-RADS to guide prostate
Fluorescent conjugates of PSMA-targeting ligand with cyanine dyes: synthetic approaches and photochemical properties
Uspenskaia Anastasiia Alekseevna, Doroshenko Irina Andreevna, Popovicheva Kseniia A., Shmychkov Nazar Vasilyvich, Levina Irina I, Beklemishev Mikhail Konstantinovich, Tashlitsky Vadim Neronovich, Podrugina Tatyana Aleksandrovna, Machulkin Aleksei Eduardovich, Beloglazkina Elena Kimovna
Fluorescent conjugates of carbocyanine dyes with a ligand selective to prostate-specific membrane
Molecular markers as diagnostic and prognostic tool in prostate cancer therapy (immunohistochemical study)
Kogan E.A., Kovalenko N.A., Markova A.S., Vinarov A.Z., Zhdanov D.D., Dobrovol'skaya O.V., Shestiperov P.A., Gorokhovets N.V.
Molecular markers of prostate cancer have been studied by immunohistochemical (IHC) methods
Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective
Sivaraman Ananthakrishnan, Bhat K.R.
to stratify patients with serum prostate specific antigen level in a grey zone of 4–10 ng/ml and normal
PROSTATIC SPECIFIC ANTIGEN IN URINE AND BLOOD IN MEN AND WOMEN
Sosnin, D.Yu., Gal’kovich, K.R., Legostina, V.A., Belokhvostikova, T.S., Akhmadullina, Yu.A., Gil’manov, A.Zh., Соснин, Д.Ю., Галькович, К.Р, Легостина, В.А., Белохвостикова, Т.С., Ахмадуллина, Ю. А., Гильманов, А.Ж.
PROSTATIC SPECIFIC ANTIGEN IN URINE AND BLOOD IN MEN AND WOMEN
Доклинические исследования терапевтической эффективности нового отечественного радиофармацевтического препарата 177Lu-ДОТА-ПСМА
Тищенко В.К., Власова О.П., Лебедева А.А., Федорова А.В., Панкратов А.А., Морозова Н.Б., Кузенкова К.А., Степченкова Е.Д., Шегай П.В., Иванов С.А., Каприн А.Д.
>Lu-DOTA-PSMA was studied in vivo using BALB/c nu/nu (nude) male mice with prostate carcinoma 22Rv1 xenografts
Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer
Davidson T., Hahiashvili M., Goshen E., Ben-Haim S., Portnoy O., Chikman B., Dotan Z., Lawrence Y.R., Symon Z., Amit U., Saad A., Goldstein A., Sadetsky I., Weizman N., Goldstein J., Berger R.
OBJECTIVES: The purpose of this study was to evaluate the use of Gallium-68 prostatic-specific
Oligometastatic prostate cancer: local treatment and metastasis-directed therapy; [Олигометастатический рак предстательной железы: локальное лечение и метастазнаправленная терапия]
Ter-Ovanesov M.D., Yagudaev D.M., Anikanova E.V., Medvedev K.I.
emission tomography/computed tomography imaging with prostate-specific membrane antigen, its combination

Страница 4 из 3166

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core